HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 01/03/2013 -- PositiveID Corporation (OTC:PSID) develops medical devices and biological detection systems focusing primarily on diabetes management, as well as airborne bio-threat detection.
PositiveID Corporation was also in the row of losers and dropped -2.63% in the December 31, 2012 session. It traded with volume of 3.43 million shares and the average trading was 1.98 million shares.
Is PSID Showing Any Sign of Buy At The Current Market Price? Find Out Here
Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) shares climbed 16.25% and closed at $2.79. The 52 week trading range for the company is $0.99 – $2.81. The shares of the company soared 178% in the last one year.
The company operates as an IC design house with LCD manufacturing capability. The Company focuses on display IC products for display device and offers LCD technical consulting to customers to provide them with value-added technical support and integrated solutions.
Can HIMX Continue To Move Lower After The Recent Gain and Investors Can Make Money? Find Out Here
Synergy Pharmaceuticals Inc. NASDAQ:SGYP) rose as much as 25% in intraday trading on Wednesday before closing 18% higher at $6.21.
The company's investigational oral drug for the treatment of chronic idiopathic constipation - Plecanatide, was well tolerated and met the primary and key secondary endpoints of a phase IIb/III clinical study.
A phase IIb study to assess Plecanatide in the treatment of irritable bowel syndrome with constipation (IBS-C) is currently underway.
Will New Regulations Weigh over SGYP Revenue Stream? Find Out Here
North American Palladium Ltd (USA) (NYSE:PAL) shares soared 11.50% at $1.45. The company, on Dec. 13, announced that Mr. Jeffrey Swinoga has resigned as Vice President Finance and Chief Financial Officer, effective January 4, 2013, to pursue a Chief Financial Officer position at another public company. The Company”s finance team has excellent depth and experience to oversee financial management until a new chief financial officer is named.
How Should Investors Trade PAL After Today’s Rally? Find Out Here
Inteliquent (NASDAQ:IQNT) shares jumped 17.12% to $3.01 in the last trading session. The company, last month, announced that it has definitively settled a previously disclosed dispute with one of its largest customers relating to the termination of certain long distance traffic. As part of the settlement, Inteliquent will make a one-time payment of $9 million in December to this customer. The settlement agreement contained a full and mutual release related to this dispute.
Is IQNT Showing Any Sign of Buy At The Current Market Price? Find Out Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)